奥住 文美, 波田野 琢, 服部 信孝. α-シヌクレイノパチー患者血液由来α-シヌクレインシードの伝播凝集メカニズム-Mechanisms Underlying the Propagation of α-Synuclein Seeds Derived from the Blood of Patients with α-Synucleinopathies. Brain and nerve. 2024. 76. 6. 767-772
Taku Hatano, Ayami Okuzumi, Gen Matsumoto, Tsunemi Taiji, Nobutaka Hattori. α-Synuclein: A Promising Biomarker for Parkinson's Disease and Related Disorders. Journal of movement disorders. 2024. 17. 2. 127-137
Taku Hatano, Genko Oyama, Yasushi Shimo, Kotaro Ogaki, Noriko Nishikawa, Ryota Nakamura, Taiji Tsunemi, Takashi Ogawa, Hiroto Eguchi, Kensuke Daida, et al. Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study. Movement disorders clinical practice. 2024. 11. 4. 352-362
Elucidation of the Pathogenesis of Synucleinopathies Focused on Blood Alpha-Synuclein Seeds
(Nuero2024 2024)
The main stream "alpha-synuclein pathology"
(日本神経学会 2024)
Identification of serum disease-specific a-synuclein seeds using IP/RT-QuIC
(ASENT 2024 Annual Meeting Evaluation 2024)
A Research for mechanism and diagnosis of synucleinopathy based on prion-like seeding hypothesis.
(AMED 革新脳国際シンポジウム 2023)
Identification of seral disease-specific a-synuclein seeds using IP/RT-QuIC
(International Congress of Parkinson’s Disease and Movement Disorders 2023)